Search Results
You are looking at 1 - 10 of 12 items for
- Author: Lin Zhang x
- Refine by access: Content accessible to me x
Search for other papers by Lin Xia in
Google Scholar
PubMed
Search for other papers by Zhongqiu Wang in
Google Scholar
PubMed
Search for other papers by Ying Zhang in
Google Scholar
PubMed
Search for other papers by Xiao Yang in
Google Scholar
PubMed
Search for other papers by Yibei Zhan in
Google Scholar
PubMed
Search for other papers by Rui Cheng in
Google Scholar
PubMed
Search for other papers by Shiming Wang in
Google Scholar
PubMed
Search for other papers by Jianfa Zhang in
Google Scholar
PubMed
A previous investigation has demonstrated that plasma 5′-AMP (pAMP) exacerbates and causes hyperglycemia in diabetic mice. However, the crosstalk between pAMP and insulin signaling to regulate glucose homeostasis has not been investigated in depth. In this study, we showed that the blood glucose level was more dependent on the ratio of insulin to pAMP than on the absolute level of these two factors. Administration of 5′-AMP significantly attenuated the insulin-stimulated insulin receptor (IR) autophosphorylation in the liver and muscle tissues, resulting in the inhibition of downstream AKT phosphorylation. A docking analysis indicated that adenosine was a potential inhibitor of IR tyrosine kinase. Moreover, the 5′-AMP treatment elevated the ATP level in the pancreas and in the isolated islets, stimulating insulin secretion and increasing the plasma level of insulin. The insulin administration decreased the 5′-AMP-induced hyper-adenosine level by the up-regulation of adenosine kinase activities. Our results indicate that blood glucose homeostasis is reciprocally regulated by pAMP and insulin.
Search for other papers by Xiaojun Zhou in
Google Scholar
PubMed
Search for other papers by Jianjun Dong in
Google Scholar
PubMed
Search for other papers by Li Zhang in
Google Scholar
PubMed
Search for other papers by Ju Liu in
Google Scholar
PubMed
Search for other papers by Xiaofeng Dong in
Google Scholar
PubMed
Search for other papers by Qing Yang in
Google Scholar
PubMed
Search for other papers by Fupeng Liu in
Google Scholar
PubMed
Search for other papers by Lin Liao in
Google Scholar
PubMed
It is well known that hyperglycemia is a trigger of atherosclerosis in patients with diabetes mellitus. However, the role of hyperglycemia in restenosis remains unclear. In this study, we investigated the effects of hyperglycemia on restenosis. Stenosis was evaluated in two sets of diabetic rabbit models: i) diabetic restenosis versus nondiabetic restenosis and ii) diabetic atherosclerosis versus nondiabetic atherosclerosis. Our results indicated that there was no difference in rates of stenosis between the diabetic and the nondiabetic groups in restenosis rabbit models. However, the incidence of stenosis was significantly higher in the diabetic atherosclerosis group compared with the nondiabetic atherosclerosis group. Similarly, the intima–media thickness and cell proliferation rate were significantly increased in the diabetic atherosclerosis group compared with the nondiabetic atherosclerosis group, but there was no difference between the diabetic restenosis and the nondiabetic restenosis groups. Our results indicate that hyperglycemia is an independent risk factor for atherosclerosis, but it has no evident effect on restenosis. These findings indicate that the processes of atherosclerosis and restenosis may involve different pathological mechanisms.
Search for other papers by Jiannan Zhang in
Google Scholar
PubMed
Search for other papers by Xin Li in
Google Scholar
PubMed
Search for other papers by Yawei Zhou in
Google Scholar
PubMed
Search for other papers by Lin Cui in
Google Scholar
PubMed
Search for other papers by Jing Li in
Google Scholar
PubMed
Search for other papers by Chenlei Wu in
Google Scholar
PubMed
Search for other papers by Yiping Wan in
Google Scholar
PubMed
Search for other papers by Juan Li in
Google Scholar
PubMed
Search for other papers by Yajun Wang in
Google Scholar
PubMed
The interaction of melanocortin-4 (MC4R) and melanocortin-3 (MC3R) receptors with proopiomelanocortin (POMC)-derived peptides (e.g. α-MSH), agouti-related protein (AgRP) and melanocortin-2 receptor accessory protein 2 (MRAP2) is suggested to play critical roles in energy balance of vertebrates. However, evidence on their interaction in birds remains scarce. Our study aims to reveal their interaction in chickens and the results showed that (1) chicken (c-)MC3R and cMC4R expressed in Chinese hamster ovary (CHO) cells can be activated by α-MSH and ACTH1–39 equipotently, monitored by a pGL3-CRE-luciferase reporter system; (2) cMC3R and cMC4R, when co-expressed with cMRAP2 (or cMRAP, a cMRAP2 homolog), show increased sensitivity to ACTH treatment and thus likely act as ACTH-preferring receptors, and the interaction between cMC3R/cMC4R and cMRAP2 was demonstrated by co-immunoprecipitation assay; (3) both cMC3R and cMC4R display constitutive activity when expressed in CHO cells, as monitored by dual-luciferase reporter assay, and cMRAP2 (and cMRAP) can modulate their constitutive activity; (4) AgRP inhibits the constitutive activity of cMC3R/cMC4R, and it also antagonizes ACTH/α-MSH action on cMC4R/cMC3R, indicating that AgRP functions as the inverse agonist and antagonist for both receptors. These findings, together with the co-expression of cMC4R, cMC3R, cMRAP2, cAgRP and cPOMC in chicken hypothalamus detected by quantitative real-time PCR, suggest that within the hypothalamus, α-MSH/ACTH, AgRP and MRAP2 may interact at the MC4R(/MC3R) interface to control energy balance. Furthermore, our data provide novel proof for the involvement of MRAP2 (and MRAP) in fine-tuning the constitutive activity and ligand sensitivity and selectivity of both MC3R and MC4R in vertebrates.
Search for other papers by Quan Wu in
Google Scholar
PubMed
Search for other papers by Ying Zhou in
Google Scholar
PubMed
Search for other papers by Linfeng Chen in
Google Scholar
PubMed
Search for other papers by Jiandang Shi in
Google Scholar
PubMed
Search for other papers by Chun-Yu Wang in
Google Scholar
PubMed
Search for other papers by Lin Miao in
Google Scholar
PubMed
Search for other papers by Helmut Klocker in
Google Scholar
PubMed
Search for other papers by Irwin Park in
Google Scholar
PubMed
Search for other papers by Chung Lee in
Google Scholar
PubMed
Search for other papers by Ju Zhang in
Google Scholar
PubMed
Estradiol (E2) level in stroma of benign prostatic hyperplasia (BPH) increases with age, and this increase was associated with an elevated expression of aromatase in prostatic stromal cells (PrSCs). Here, we showed that conditioned medium (CM) of BPH-1 (a benign hyperplastic prostatic epithelial cell line), but not of prostate cancer cell lines (LNCaP, DU-145, and PC-3), stimulates aromatase expression in PrSCs. Cyclooxygenase-2 (COX-2) mRNA level in BPH-1, as well as prostaglandin E2 (PGE2) concentration in BPH-1 CM, was significantly higher than that of prostate cancer cell lines. CM of BPH-1 treated with NS-398 (a specific inhibitor of COX-2) failed to stimulate aromatase expression in PrSCs. And PGE2 can stimulate aromatase expression in PrSCs. Our data suggested that BPH-1 induced aromatase expression in PrSCs through the production of PGE2 in a paracrine mechanism.
Search for other papers by Chun Zeng in
Google Scholar
PubMed
Search for other papers by Xin Yi in
Google Scholar
PubMed
Search for other papers by Danny Zipris in
Google Scholar
PubMed
Search for other papers by Hongli Liu in
Google Scholar
PubMed
Search for other papers by Lin Zhang in
Google Scholar
PubMed
Search for other papers by Qiaoyun Zheng in
Google Scholar
PubMed
Search for other papers by Krishnamurthy Malathi in
Google Scholar
PubMed
Search for other papers by Ge Jin in
Google Scholar
PubMed
Clinical Chemistry Program, Center for Gene Regulation in Health and Diseases, Department of Cancer Biology, Barbara Davis Center of Childhood Diabetes, Central Laboratory, Department of Biological Sciences, Department of Biological Sciences, Department of Chemistry, Cleveland State University, SI 424, Cleveland, Ohio 44115, USA
Clinical Chemistry Program, Center for Gene Regulation in Health and Diseases, Department of Cancer Biology, Barbara Davis Center of Childhood Diabetes, Central Laboratory, Department of Biological Sciences, Department of Biological Sciences, Department of Chemistry, Cleveland State University, SI 424, Cleveland, Ohio 44115, USA
Search for other papers by Aimin Zhou in
Google Scholar
PubMed
The cause of type 1 diabetes continues to be a focus of investigation. Studies have revealed that interferon α (IFNα) in pancreatic islets after viral infection or treatment with double-stranded RNA (dsRNA), a mimic of viral infection, is associated with the onset of type 1 diabetes. However, how IFNα contributes to the onset of type 1 diabetes is obscure. In this study, we found that 2-5A-dependent RNase L (RNase L), an IFNα-inducible enzyme that functions in the antiviral and antiproliferative activities of IFN, played an important role in dsRNA-induced onset of type 1 diabetes. Using RNase L-deficient, rat insulin promoter-B7.1 transgenic mice, which are more vulnerable to harmful environmental factors such as viral infection, we demonstrated that deficiency of RNase L in mice resulted in a significant delay of diabetes onset induced by polyinosinic:polycytidylic acid (poly I:C), a type of synthetic dsRNA, and streptozotocin, a drug which can artificially induce type 1-like diabetes in experimental animals. Immunohistochemical staining results indicated that the population of infiltrated CD8+T cells was remarkably reduced in the islets of RNase L-deficient mice, indicating that RNase L may contribute to type 1 diabetes onset through regulating immune responses. Furthermore, RNase L was responsible for the expression of certain proinflammatory genes in the pancreas under induced conditions. Our findings provide new insights into the molecular mechanism underlying β-cell destruction and may indicate novel therapeutic strategies for treatment and prevention of the disease based on the selective regulation and inhibition of RNase L.
Search for other papers by Shuisheng Li in
Google Scholar
PubMed
Search for other papers by Yong Zhang in
Google Scholar
PubMed
Search for other papers by Yun Liu in
Google Scholar
PubMed
Search for other papers by Xigui Huang in
Google Scholar
PubMed
Search for other papers by Weiren Huang in
Google Scholar
PubMed
Search for other papers by Danqi Lu in
Google Scholar
PubMed
Search for other papers by Pei Zhu in
Google Scholar
PubMed
Search for other papers by Yu Shi in
Google Scholar
PubMed
Search for other papers by Christopher H K Cheng in
Google Scholar
PubMed
Search for other papers by Xiaochun Liu in
Google Scholar
PubMed
State Key Laboratory of Biocontrol, Department of Biochemistry, College of Ocean, Institute of Aquatic Economic Animals, and the Guangdong Province Key Laboratory for Aquatic Economic Animals, Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
Search for other papers by Haoran Lin in
Google Scholar
PubMed
To ascertain the neuroendocrine function of the kisspeptin/GPR54 system in non-mammalian species, full-length cDNAs encoding for Kiss1 and Kiss2 as well as their putative cognate receptors GPR54a and GPR54b, were isolated from goldfish (Carassius auratus). The deduced protein sequences between Kiss1 and Kiss2 in goldfish share very low similarity, but their putative mature peptides (kisspeptin-10) are relatively conserved. RT-PCR analysis demonstrated that the goldfish kiss1 gene (gfkiss1) is highly expressed in the optic tectum-thalamus, intestine, kidney, and testis, while the goldfish kiss2 gene (gfkiss2) is mainly detected in the hypothalamus, telencephalon, optic tectum thalamus, adipose tissue, kidney, heart, and gonads. The two receptor genes (gfgpr54a and gfgpr54b) are highly expressed in the brain regions including telencephalon, optic tectum thalamus, and hypothalamus. Both mature goldfish kisspeptin-10 peptides (gfKiss1–10 and gfKiss2–10) are biologically active as they could functionally interact with the two goldfish receptors expressed in cultured eukaryotic cells to trigger the downstream signaling pathways with different potencies. The actions of gfKiss1–10 and gfKiss2–10 on LH secretion were further investigated in vitro and in vivo. Intraperitoneal administration of gfKiss1–10 to sexually mature female goldfish could increase the serum LH levels. However, this peptide does not significantly influence LH release from goldfish pituitary cells in primary culture, indicating that the peptide does not exert its actions at the pituitary level. On the other hand, gfKiss2–10 appears to be a much less potent peptide as it exhibits no significant in vivo bioactivity and is also inactive on the primary pituitary cells.
Search for other papers by Yong Zhang in
Google Scholar
PubMed
Search for other papers by Yun Liu in
Google Scholar
PubMed
Search for other papers by Xigui Huang in
Google Scholar
PubMed
Search for other papers by Xiaochun Liu in
Google Scholar
PubMed
Search for other papers by Baowei Jiao in
Google Scholar
PubMed
Search for other papers by Zining Meng in
Google Scholar
PubMed
Search for other papers by Pei Zhu in
Google Scholar
PubMed
Search for other papers by Shuisheng Li in
Google Scholar
PubMed
State Key Laboratory of Biocontrol, Department of Biochemistry, College of Ocean, School of Life Sciences, Institute of Aquatic Economic Animals, and the Guangdong Province Key Laboratory for Aquatic Economic Animals, Sun Yat-Sen University, Guangzhou 510275, China
Search for other papers by Haoran Lin in
Google Scholar
PubMed
Search for other papers by Christopher H K Cheng in
Google Scholar
PubMed
Two GPR39 transcripts, designated as sbGPR39-1a and sbGPR39-1b, were identified in black seabream (Acanthopagrus schlegeli). The deduced amino acid (aa) sequence of sbGPR39-1a contains 423 residues with seven putative transmembrane (TM) domains. On the other hand, sbGPR39-1b contains 284 aa residues with only five putative TM domains. Northern blot analysis confirmed the presence of two GPR39 transcripts in the seabream intestine, stomach, and liver. Apart from seabream, the presence of two GPR39 transcripts was also found to exist in a number of teleosts (zebrafish and pufferfish) and mammals (human and mouse). Analysis of the GPR39 gene structure in different species suggests that the two GPR39 transcripts are generated by alternative splicing. When the seabream receptors were expressed in cultured HEK293 cells, Zn2 + could trigger sbGPR39-1a signaling through the serum response element pathway, but no such functionality could be detected for the sbGPR39-1b receptor. The two receptors were found to be differentially expressed in seabream tissues. sbGPR39-1a is predominantly expressed in the gastrointestinal tract. On the other hand, sbGPR39-1b is widely expressed in most central and peripheral tissues except muscle and ovary. The expression of sbGPR39-1a in the intestine and the expression of sbGPR39-1b in the hypothalamus were decreased significantly during food deprivation in seabream. On the contrary, the expression of the GH secretagogue receptors (sbGHSR-1a and sbGHSR-1b) was significantly increased in the hypothalamus of the food-deprived seabream. The reciprocal regulatory patterns of expression of these two genes suggest that both of them are involved in controlling the physiological response of the organism during starvation.
Search for other papers by Lu Fu in
Google Scholar
PubMed
Institute of Cardiovascular Disease Research, Xuzhou Medical University, Xuzhou, China
Search for other papers by Hongyuan Zhang in
Google Scholar
PubMed
Search for other papers by Jeremiah Ong’achwa Machuki in
Google Scholar
PubMed
Institute of Cardiovascular Disease Research, Xuzhou Medical University, Xuzhou, China
Search for other papers by Tingting Zhang in
Google Scholar
PubMed
Search for other papers by Lin Han in
Google Scholar
PubMed
Search for other papers by Lili Sang in
Google Scholar
PubMed
Institute of Cardiovascular Disease Research, Xuzhou Medical University, Xuzhou, China
Search for other papers by Lijuan Wu in
Google Scholar
PubMed
Institute of Cardiovascular Disease Research, Xuzhou Medical University, Xuzhou, China
Search for other papers by Zhiwei Zhao in
Google Scholar
PubMed
Search for other papers by Matthew James Turley in
Google Scholar
PubMed
Search for other papers by Xide Hu in
Google Scholar
PubMed
Search for other papers by Hongjian Hou in
Google Scholar
PubMed
Search for other papers by Dongye Li in
Google Scholar
PubMed
Search for other papers by Sian E Harding in
Google Scholar
PubMed
Search for other papers by Hong Sun in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China
Search for other papers by You-Hua Xu in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China
Department of Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
Search for other papers by Chen-Lin Gao in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China
Search for other papers by Heng-Li Guo in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China
Search for other papers by Wen-Qian Zhang in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China
Department of Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
Search for other papers by Wei Huang in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China
Search for other papers by Shan-Shan Tang in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China
Search for other papers by Wen-Jun Gan in
Google Scholar
PubMed
Department of Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
Search for other papers by Yong Xu in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China
Search for other papers by Hua Zhou in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China
Search for other papers by Quan Zhu in
Google Scholar
PubMed
Endotoxemia has been recognized to be closely accompanied with type 2 diabetes mellitus (T2DM) and is responsible for many diabetic complications. Recent study suggests the potential role of butyrate, a short-chain fatty acid (SCFA) from microbiota metabolite, on T2DM. Gut-leak is a key event in diabetic-endotoxemia. To investigate if butyrate could ameliorate diabetic-endotoxemia, both in vivo and in vitro experiments were carried out in the present study. The effect of butyrate supplementation on blood HbA1c and inflammatory cytokines were determined in db/db mice; gut barrier integrity and expression of tight junction proteins were investigated both in vivo and in vitro. Oral butyrate administration significantly decreased blood HbA1c, inflammatory cytokines and LPS in db/db mice; inflammatory cell infiltration was reduced, and gut integrity and intercellular adhesion molecules were increased as detected by HE staining, immunohistochemistry and Western blot. By gut microbiota assay, ratio of Firmicutes:Bacteroidetes for gut microbiota was reduced by butyrate. In Caco-2 cells, butyrate significantly promoted cell proliferation, decreased inflammatory cytokines’ secretion, enhanced cell anti-oxidative stress ability and preserved the epithelial monocellular integrity, which was damaged by LPS. The present findings demonstrated that butyrate supplementation could ameliorate diabetic-endotoxemia in db/db mice via restoring composition of gut microbiota and preserving gut epithelial barrier integrity.
Basic Medical College of Nanyang Medical University, Nanyang, China
Search for other papers by Lin-guo Pei in
Google Scholar
PubMed
Search for other papers by Qi Zhang in
Google Scholar
PubMed
Search for other papers by Chao Yuan in
Google Scholar
PubMed
Search for other papers by Min Liu in
Google Scholar
PubMed
Search for other papers by Yun-fei Zou in
Google Scholar
PubMed
Search for other papers by Feng Lv in
Google Scholar
PubMed
Search for other papers by Da-ji Luo in
Google Scholar
PubMed
Search for other papers by Shan Zhong in
Google Scholar
PubMed
Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China
Search for other papers by Hui Wang in
Google Scholar
PubMed
Prenatal caffeine exposure (PCE) can induce testicular developmental toxicity. Here, we aimed to explore the underlying mechanism of this process in reference to its intrauterine origin. Pregnant rats were intragastrically administrated caffeine (30 and 120 mg/kg/day) from gestational days 9 to 20. The results showed that the male fetuses exposed to high dose of caffeine (120 mg/kg/day) had a decreased bodyweight and inhibited testosterone synthetic function. Meanwhile, their serum corticosterone concentration was elevated and their testicular insulin-like growth factor 1 (Igf1) expression was decreased. Moreover, the histone 3 lysine 14 acetylation (H3K14ac) level in the Igf1 promoter region was reduced. Low-dose (30 mg/kg/day) caffeine exposure, however, increased steroidogenic enzymes expression in male fetuses. After birth, the serum corticosterone concentration gradually decreased in the PCE (120 mg/kg/day) offspring rats, whereas the expression and H3K14ac level of Igf1 gradually increased, with obvious catch-up growth and testicular development compensation. Intriguingly, when we subjected the offspring to 2 weeks of chronic stress to elevate the serum corticosterone concentration, the expression of Igf1 and testosterone synthesis were inhibited again in the PCE (120 mg/kg/day) group, accompanied by a decrease in the H3K14ac level in the Igf1 promoter region. In vitro, corticosterone (rather than caffeine) was proved to inhibit testosterone production in Leydig cells by altering the H3K14ac level and the expression of Igf1. These observations suggested that PCE-induced testicular developmental toxicity is related to the negative regulation of corticosterone on H3K14ac levels and the expression of Igf1.
